Novel imidazolium-thiohydantoin hybrids and their Mn(<scp>iii</scp>) complexes for antimicrobial and anti-liver cancer applications-Reference-Cited by-同舟云学术

Novel imidazolium-thiohydantoin hybrids and their Mn(iii) complexes for antimicrobial and anti-liver cancer applications

Published:2022 Issue:44 Volume:12 Page:28364-28375
ISSN:2046-2069
Container-title:RSC Advances
language:en
Short-container-title:RSC Adv.

Author:

Ismail Lamia A.¹,Zakaria R.¹,Hassan Eman M.¹,Alfaifi Mohammad Y.²,Shati Ali A.²,Elbehairi Serag Eldin I.²³,El-Bindary A. A.⁴,Elshaarawy Reda F. M.⁵⁶^ORCID

Affiliation:

1. Department of Chemistry, Faculty of Science, Port Said University, Port Said 42526, Egypt

2. Biology Department, Faculty of Science, King Khalid University, Abha 9004, Saudi Arabia

3. Cell Culture Lab, Egyptian Organization for Biological Products and Vaccines (VACSERA Holding Company), Giza 12311, Egypt

4. Chemistry Department, Faculty of Science, Damietta University, Damietta, 34517, Egypt

5. Department of Chemistry, Faculty of Science, Suez University, Suez 43533, Egypt

6. Institut für Anorganische Chemie und Strukturchemie, Heinrich-Heine Universität Düsseldorf, Düsseldorf, Germany

Abstract

We present the effective synthesis and structural characterization of three novel imidazolium-thiohydantoin ligands (IMTHs, 5a–c) and their Mn(iii) complexes (Mn(iii)IMTHs, 6a–c) in this study.

Funder

King Khalid University

Publisher

Royal Society of Chemistry (RSC)

Subject

General Chemical Engineering,General Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2022/RA/D2RA05233D

Reference57 articles.

1. Multidrug Resistance (MDR): A Widespread Phenomenon in Pharmacological Therapies

2. Emerging Strategies to Combat ESKAPE Pathogens in the Era of Antimicrobial Resistance: A Review

3. Efficient drug discovery by rational lead hybridization based on crystallographic overlay